Andreas Treml

Biography

Andreas Treml received his Ph.D. in biology from the University of Regensburg in 1997. He worked in the field of therapeutic oncology and characterized the mode of action of novel nonsteroidal antiestrogens on steroid hormone receptors and the involvement of further transcription factors. Prior to Origenis he developed the high throughput facilities of Morphochem AG where he was responsible for assay development and adaptation for parallel library testing. He also developed the automated HTSS® (high throughput secondary screening) which plays an important role for compound profiling using the MOREsystem®. As one of the inventors of the proprietary MOREsystem®, he is responsible for the integration of biological screening and compound characterization into the interdisciplinary process. Andreas Treml received his Ph.D. in biology from the University of Regensburg in 1997. He worked in the field of therapeutic oncology and characterized the mode of action of novel nonsteroidal antiestrogens on steroid hormone receptors and the involvement of further transcription factors. Prior to Origenis he developed the high throughput facilities of Morphochem AG where he was responsible for assay development and adaptation for parallel library testing. He also developed the automated HTSS® (high throughput secondary screening) which plays an important role for compound profiling using the MOREsystem®. As one of the inventors of the proprietary MOREsystem®, he is responsible for the integration of biological screening and compound characterization into the interdisciplinary process.

Research Interest

steroid hormone receptors, neurotechnology,biological screening and compound characterization.